|Articles|July 2, 2004
- Pharmaceutical Technology-07-02-2004
- Volume 28
- Issue 7
Politics Versus Science in Biomedical Research and Development
Author(s)Jill Wechsler
Decisions to accelerate the approval of AIDS combination drugs, reject the over-the-counter status for the morning-after pill, and limit support for stem cell research are hot political topics.
Advertisement
Articles in this issue
about 22 years ago
3M Drug Delivery Systemsabout 22 years ago
AccuRateabout 22 years ago
July 2004about 22 years ago
Investors Shy Away from Pharmaceutical Chemicalsabout 22 years ago
In the Spotlight-July 2004about 22 years ago
A Stability Program for the Distribution of Drug ProductsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know about BMS & NVidia’s AI Supercomputer
2
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
3
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
4
From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026
5